1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025

  • January 2017
  • 79 pages
  • GlobalData
Report ID: 3321282

Summary

Table of Contents

Search Inside

EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025

Summary

Human immunodeficiency virus (HIV) is a lentivirus that impairs and destructs the CD4 cells of the immune system (Simon et al., 2006). This weakens the immune system, leaving an infected individual more susceptible to other illnesses and, over time, impairing the individual’s ability to fight off infections. Once an infected person has a CD4 cell count of less than 200 cells per ?l, HIV has developed into acquired immunodeficiency syndrome (AIDS), which is the most advanced stage of HIV.

In 2015, UNAIDS reported 36.7 Million people to be living with HIV globally, an increase of 3.4 Million from 2010 (UNAIDS, 2016a). It was also reported that there was a significant increase in the number of people living with HIV on ART between 2010 and 2015. In 2010, approximately 7.5 Million people with HIV were receiving ART, and by 2015 this had increased by over 125% to approximately 17.0 Million people.

Epidemiologists forecast that the total prevalent cases of HIV in the 8MM will increase from 3,632,410 in 2015 to 4,266,548 in 2025 at an Annual Growth Rate (AGR) of 1.75%. The US will have the highest number of total prevalent cases of HIV in both 2015 and 2025 at 1,315,263 and 1,514,925, respectively.

In 8MM, epidemiologists forecast that the diagnosed prevalent cases of HIV will increase from 2,926,335 in 2015 to 3,616,811 in 2025 at an AGR of 2.36%. The US will have the highest number of diagnosed prevalent cases of HIV in both 2015 and 2025; however, the UK and China will have the highest AGRs at 3.26% and 3.23%, respectively.

The report “EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends for HIV in the nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Brazil, and China). For the 8MM (US, France, Germany, Italy, Spain, UK, Brazil, and China) it also includes a 10-year epidemiological forecast for the total prevalent cases of HIV (both sexes and all ages), and diagnosed prevalent cases of HIV segmented by sex and age from 2015–2025. The diagnosed prevalent cases of HIV are further segmented into those receiving antiretroviral therapy (ART), those with hepatitis B virus (HBV) co-infection, and those with hepatitis C virus (HCV) co-infection.

Scope

- The Humman Immunodeficiency Virus (HIV) EpiCast Report provides an overview of the risk factors and global trends for HIV in the nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Brazil, and China). For the 8MM (US, France, Germany, Italy, Spain, UK, Brazil, and China) it also includes a 10-year epidemiological forecast for the total prevalent cases of HIV (both sexes and all ages), and diagnosed prevalent cases of HIV segmented by sex and age from 2015-2025. The diagnosed prevalent cases of HIV are further segmented into those receiving antiretroviral therapy (ART), those with hepatitis B virus (HBV) co-infection, and those with hepatitis C virus (HCV) co-infection. For Japan, GlobalData epidemiologists provide a 10-year forecast for the 20-year diagnosed prevalent cases of HIV segmented by sex and age from 2015-2025. The 20-year diagnosed prevalent cases of HIV are further segmented into those receiving ART, those with HBV co-infection, and those with HCV co-infection.
- The HIV epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

The HIV EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global HIV market.
- Quantify patient populations in the global HIV market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for HIV therapeutics in each of the markets covered.
- Understand co-infection population and ART treated population for HIV patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global HIV Diagnosis Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insights by Product, by Type of Test, by End User

  • $ 5100
  • Industry report
  • July 2017
  • by P&S Market Research

Market Overview HIV diagnosis refers to the test performed to detect the presence of human immunodeficiency virus (HIV) in humans. HIV attacks the immune system targeting CD4 cells, also known as T cells. ...

Global Blotting Systems Market 2017-2021

  • $ 3500
  • Industry report
  • June 2017
  • by Infiniti Research Limited

About Blotting Systems Blotting system is used for the detection of nucleic acids or proteins from specific tissue or cell samples. Blotting systems are an essential part of any molecular diagnostic procedure ...

Global Kaposi Sarcoma Market 2017-2021

  • $ 3500
  • Industry report
  • May 2017
  • by Infiniti Research Limited

About Kaposi Sarcoma Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.